Sale of Zohydro ER business (Tables)

3 Months Ended

Mar. 31, 2015

Discontinued Operations and Disposal Groups [Abstract]

Schedule of Results of Discontinued Operations

The following table summarizes the results of discontinued operations for the periods presented the consolidated statements of operations and comprehensive loss for the three months ended March 31, 2015 and 2014 (in thousands):

	Three Months Ended March 31,
Discontinued operations	2015			2014
Revenues:
Net product revenue	$	5,006		$	285
Operating expenses:
Cost of product sold	1,340			49
Royalty expense	418			96
Research and development	4,808			997
Selling, general and administrative	11,136			15,123
Total operating expenses	17,702			16,265
Loss from discontinued operations	$	(12,696	)	$	(15,980	)

The following table summarizes the assets and liabilities of discontinued operations as of March 31, 2015 and December 31, 2014 related to the Zohydro ER business (in thousands):

	March 31, 2015		December 31, 2014
ASSETS
Current assets
Trade accounts receivable	$	3,046	$	2,799
Inventory	787		1,995
Prepaid expenses	1,700		1,767
Other current assets	1,103		635
Total current assets of discontinued operations	6,636		7,196
Other assets	3,405		2,673
Total assets of discontinued operations	$	10,041	$	9,869
LIABILITIES
Current liabilities
Accounts payable	$	4,786	$	3,781
Accrued expenses	9,983		9,470
Accrued compensation	1,747		1,933
Deferred revenue	4,881		7,123
Total current liabilities of discontinued operations	21,397		22,307
Total liabilities of discontinued operations	$	21,397	$	22,307